Original Research ARTICLE
Antimicrobial Resistance and Molecular Characterization of Staphylococcus aureus Causing Childhood Pneumonia in Shanghai
- 1Faculty of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- 2Department of Clinical Microbiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- 3Department of Immunology and Microbiology, Institutes of Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Staphylococcus aureus or methicillin-resistant Staphylococcus aureus (MRSA) is a major pathogen causing pneumonia among children. To estimate the prevalence and molecular properties of S. aureus in children pneumonia in Shanghai, China, 107 hospitalized children with S. aureus pneumonia from two children's hospitals from January 2014 through June 2015 were studied. S. aureus isolates from the respiratory specimens were characterized by antimicrobial susceptibility, agr typing, toxin genes, multilocus sequence typing (MLST), spa, and SCCmec typing. Fifty-eight (54.2%, 58/107) were MSSA (methicillin-susceptible Staphylococcus aureus) and 49 (45.8%, 49/107) were MRSA. No isolates were found resistant to teicoplanin, sulfamethoxazole/trimethoprim, rifampicin, quinupristin/dalfopristin, linezolid, or vancomycin. However, these isolates showed high resistant rates to erythromycin, fosfomycin-trometamol and clindamycin. The agrI (87/107, 81.3%) was the most common agr allele, followed by agrIII(10/107, 9.3%), agrII(9/107, 8.4%), and agrIV(1/107, 0.9%). Six pvl-positive isolates (3 MRSA and 3 MSSA) and 7 isolates of livestock associated clone ST398 (4 MRSA, 3 MSSA) were identified. CC59 was found in 35 isolates (33 MRSA and 2 MSSA), constituting majority of MRSA (33/49, 67.35%). The dominant CC were CC59 (32.7%), CC188 (13.1%), CC7 (12.1%) and CC398 (9.3%) while t172 (16.8%), t189 (12.1%), t437 (9.3%), and t091 (9.3%) were the most common spa types. In conclusion, more particular concern should appeal to ST59-SCCmecIV-t172/t437 as it is the most common epidemic clone causing pneumonia among children in Shanghai.
Pneumonia causes high mortality among children under 5 years old. According to data from the World Health Organization, there are more children died from pneumonia than AIDS, malaria and measles combined (Adegbola, 2012). In industrialized countries, 1–10% of community-acquired and 20–50% of nosocomial bacterial pneumonia in children were caused by S. aureus (Bradley, 2005; Chisti et al., 2009). First reported in 1961, soon after the clinical introduction of methicillin, MRSA (methicillin-resistant Staphylococcus aureus) has become major nosocomial pathogen worldwide, and was found in the community (community-associated MRSA, CA-MRSA) in the late 1980s. Four pediatric necrotizing pneumonia caused by CA-MRSA in 1999 raised a global public health concern (Centers for Disease Control and Prevention, 1999). Now it has been estimated that up to 40% of patients with CA-MRSA had severe or fatal pneumonia (Wallin et al., 2008; Carcillo et al., 2009).
Several CA-MRSA clones have been reported with different regional prevalence, while ST30 clones are found worldwide (Aires De Sousa et al., 2003; Hsu et al., 2006). ST8 (USA300) and ST1 (USA400) are mostly reported in the United States and Canada (Mulvey et al., 2005; Tenover et al., 2006), ST80 is the prevalent clone in Europe (Holmes et al., 2005; Wannet et al., 2005; Fossum and Bukholm, 2006), and ST59 spreads mostly in the Asian-Pacific area (Coombs et al., 2004; Ho et al., 2007; Huang and Chen, 2011).
In recent years, some researchers reported MRSA infections in Chinese children. ST239 and ST59 were common clones in hospital- associated infections caused by MRSA (Ning et al., 2015). However, rare data of prevalence, antimicrobial susceptibility and molecular epidemiology of MRSA causing childhood pneumonia were available in Shanghai. We conducted a study on the resistance phenotype and sequence types (STs) of S. aureus isolates from two pediatric hospitals in Shanghai.
Materials and Methods
This study was conducted in two tertiary teaching children's hospitals in Shanghai, offering comprehensive pediatric in-patient and out-patient services for approximately 21,000 inpatients and 1.25 million outpatients from Shanghai metropolitan area and eastern provinces annually. The two hospitals are located Pudong and Puxi districts respectively, being 14.1 kilometers apart from each other. One hundred and seven pediatric inpatients with pneumonia caused by S. aureus from January 2014 to June 2015 were enrolled in the study. Diagnosis of pneumonia are based on clinical presentations (acute clinical deterioration, pulse oximetry, increased respiratory support requirement), radiological findings (presence of new or changing infiltrate on chest radiography) and laboratory tests (elevated C-reactive protein or abnormal white blood cell count).
One hundred and seven S. aureus isolates from 107 children with pneumonia were collected, which were identified by combination of phenotypic tests as previously described (Chen et al., 2012).
This study was approved by Ruijin Hospital Ethics Committee (Shanghai Jiao Tong University School of Medicine), and the Review Board exempted the need for informed consent because this retrospective study mainly focused on bacteria and did no interventions to patients.
A total of 107 S. aureus isolates were identified. The sample types included throat swabs (1/107, 0.9%), sputum (104/107, 97.2%) and bronchoalveolar lavage (2/107, 1.9%). S. aureus isolated from sputum represented lower respiratory tract there are 25 PMN and less than 10 epithelial cells per low power field. Seventy-one males and 36 females were enrolled and their median age was 51 days (range: 3–1,825 days).
Antimicrobial Susceptibility Tests
The antimicrobial susceptibility tests were conducted by disk diffusion method according to the guidelines of CLSI M100-S25 (Patel et al., 2015). The antibiotics included penicillin (10 units), cefoxitin (30 μg), gentamicin (10 μg), kanamycin (30 μg), tobramycin (10 μg), fosfomycin-trometamol (200 μg), erythromycin (15 μg), tetracycline (30 μg), teicoplanin (30 μg), minocycline (30 μg), ciprofloxacin (5 μg), clindamycin (2 μg), sulfamethoxazole-trimethoprim (25 μg), chloramphenicol (30 μg), rifampicin (5 μg), quinupristin-dalfopristin (15 μg) and linezolid (30 μg). The penicillin disk diffusion zone edge test was used for β-lactamase detection, and inducible clindamycin resistance was examined by the D-test. The minimum inhibitory concentration (MIC) of vancomycin was detected by the agar dilution method. S. aureus ATCC25923 and ATCC29213 were used for quality control.
DNA was extracted by the simplified alkaline-lysis method (Chen et al., 2012). All S. aureus isolates were performed with spa typing, accessory gene regulator (agr) typing and multilocus sequence typing (MLST) (Chen et al., 2013). MRSA strains were confirmed by presence of the mecA gene, and SCCmec types of MRSA were determined as previously described (Ito et al., 2014).
Detection of Toxin Genes
The Toxin gene profiles were performed by PCR, and candidate genes includes lukS/F-PV (encoding Panton-Valentine leukocidin); tst (encoding toxic shock syndrome toxin 1); eta and etb (encoding exfoliative toxin A and B); sea-see and seg-sej (encoding staphylococcal enterotoxins SEA-SEE and SEG-SEJ) (Jarraud et al., 2002), and sasX (encoding a mobile genetic element) which also acts as a virulence determinant and plays a key role in MRSA colonization and pathogenesis (Li et al., 2012).
SPSS 22.0 (SPSS Inc., Chicago IL, USA) was used for Data analysis, including the chi-square or Fisher's exact test. A two-sided p < 0.05 was considered to be statistically significant.
Antimicrobial Susceptibility Tests
Among 107 S. aureus isolates, 49 (45.8%) were MRSA, and 58 (54.2%) were methicillin-susceptible S. aureus (MSSA) according to CLSI M100-S25 guidelines. All isolates were susceptible to teicoplanin, sulfamethoxazole-trimethoprim, rifampicin, quinupristin-dalfopristin, linezolid and vancomycin. Only one MRSA isolate was intermediate to minocycline. Three ciprofloxacin-resistant (2.8%) and 14 ciprofloxacin-intermediate (13.1%) isolates were found. The ciprofloxacin-resistant isolates belonged to ST764, ST88, and ST2315, while all ciprofloxacin-intermediate isolates were ST59-SCCmecIV-t172. Seven (6.5%) penicillin-susceptible isolates were β-lactamase positive. A total of 20 isolates (10 MRSA and 10 MSSA) were inducible resistance to clindamycin as determined by D-test. MSSA isolates had significantly higher susceptibility than MRSA isolates in the following antibiotics: penicillin, tobramycin, erythromycin, clindamycin and ciprofloxacin (Table 1).
The seb (42/107, 39.3%) was the most frequent toxin gene, followed by sea (28/107, 26.2%). No etb, see, sasX were found. sec, sed, she, and sej were only found in MSSA isolates. There was a significant difference between MRSA and MSSA isolates in prevalence among the toxin genes of sea, seb, seg, and sei (Table 2). Six S. aureus isolates carried lukS/F-PV gene, and three of which were MRSA.
Thirty eight isolates belonged to SCCmec typeIV and 8 belonged to SCCmec typeIV. Three MRSA isolates could not be SCCmec typed. Forty Spa types were identified. t172 (18/107, 16.8%) was the most common, followed by t189 (13/107, 12.1%), t091, and t437 (10/107, 9.3%). t172 (17/49, 34.7%) and t189 (13/58, 22.4%) were the most common spa type in MRSA and MSSA respectively.
Among all S. aureus isolates, 20 sequence types (STs) were identified by MLST. The most common ST was ST59 (35/107, 32.7%), followed by ST188 (14/107, 13.1%), ST7 (13/107, 12.1%), and ST398 (10/107, 9.3%). Eighteen clonal complexes (CCs) were identified, classified into one group (CC8) and 17 singletons by eBURST. CC59 (35/107, 32.7%) was the most common clone, followed by CC188 (14/107, 13.1%), CC7 (13/107, 12.1%) and CC398 (10/107, 9.3%) (Table 3 and Figure 1). ST59-SCCmec IV-t172 (17/49, 34.7%) was the most common clone in MRSA, followed by ST59-SCCmecIV-t437 (9/49, 18.4%). In ST59-SCCmec IV-t172 clone erythromycin, clindamycin and fosfomycin-trometamol had same resistance rate, which was up to 76.4%. Moreover, ST59-SCCmec IV-t437 clone showed high resistance to erythromycin, clindamycin and kanamycin as well, which was 88.9, 88.9, and 77.8% respectively. ST188-t189 (13/58, 22.4%) was the most common clone in MSSA, followed by ST7-t091 (10/58, 17.2%). Resistance rates of Penicillin in ST188-t189 and ST7-t091 were 92.3 and 90% respectively. Additionally, ST59 was the most frequent ST in lukS/F-PV-positive isolates, including 2 SCCmec typeV and 1 SCCmec type IV isolates. Other STs found in lukS/F-PV-positive isolates included ST217 (1MSSA), ST398 (1MSSA) and ST6 (1MSSA).
Table 3. Molecular characteristics and antibiotic resistance profiles of S. aureus isolated from children with pneumonia.
Figure 1. The diagram generated by eBURST with the default group definition based on the MLST data of this study, illustrating the relations of 107 S. aureus isolates. Each number implies an MLST ST and the dot area indicates the prevalence of the ST in the MLST data of this study.
Grouping of agr allele showed that agr I to IV was discovered in 87, 10, 9 and 1 isolates respectively. agrI (87/107, 81.3%) was the most common agr group, followed by agrIII (10/107, 9.3%), agrII (9/107, 8.4%), and agr IV (1/107, 0.9%). No significant difference was observed in the prevalence of agr allele between MSSA and MRSA.
The morbidity of childhood pneumonia caused by S. aureus particularly CA-MRSA has been increasing over the past two decades (Gonzalez et al., 2005; David and Daum, 2010). Among the 107 pediatric S. aureus pneumonia patients enrolled in current study, 49 isolates were CA-MRSA according to the definition by J. A. Otter et al and the epidemiological data in Asian pacific area (Ho et al., 2012; Otter et al., 2013; Xiao et al., 2013; Zhang H. et al., 2015). Unlike similar study conducted in Shanghai in 2005, which showed ST239, ST910, and ST88 were the main endemic S. aureus clones causing infections (Zhang et al., 2009), we found that CC59 was the most common CC, and it was also the most common CC among MRSA isolates in Shanghai. In 2009, Chen et al found HA-MRSA stains were still the major pathogen in healthcare- associated bloodstream or secondary to thermal injury in audit in Shanghai, and two main MRSA clones (ST239 and ST5) were prevailing in patients (Chen et al., 2012, 2013). ST239 was also reported as an epidemic clone causing S. aureus surgical site infections in orthopedic patients in Shanghai in 2011 (Gu et al., 2015a). Nevertheless, ST239 was not detected in our study, and CC8 (ST8, ST630, ST1821) was discovered in only 3 isolates. It seemed that ST59 had replaced ST239 in terms of dissemination in Shanghai. STs which proved capable of developing high-level of resistance to fluoroquinolones without suffering significant fitness cost would supplant others. However, other factors would determine clonal shifts in facilities/wards where fluoroquinolones are inappropriate in use (Fuzi, 2016). The dominant MRSA sequence type replacements are worth further studies. A study performed in 2008 showed ST59-SCCmec IV-t437 was the predominant clone of CA-MRSA which caused community –onset childhood pneumonia in China (Geng et al., 2010); however, the present study suggested that ST59-SCCmec IV-t172 had replaced ST59-SCCmec IV-t437 as the most common clone in CA-MRSA in Shanghai. Gu's study implied CC59 was the most common CC among adult patients with skin and soft tissue infections (SSTIs) in Shanghai in 2011 (Gu et al., 2015b). The study conducted among nursing home residents in Shanghai in 2014 showed CC1 was the most common clonal of S. aureus carriage (Zhang J. et al., 2015). This might indicate that CC59 is common in SSTIs and pneumonia, and will not be affected by population factors. CC398 was also recently reported as a livestock-associated clone in skin and soft-tissue infections (SSTIs) in China (Gu et al., 2015b) and the spa type t034 (CC398) is a typical livestock-associated spa type. In Europe, patients carrying this spa type are usually in contact with major animal reservoir (mostly pigs) carrying these MRSA (Köck et al., 2009). Livestock-associated S. aureus CC398 (ST398 with t034) was found in 7 isolates (4MRSA and 3 MSSA), and the SCCmec type of all CA-MRSA was V in this study. Clinical data on any possible children contact are not available in this study, but all children infected by ST398-t034 S. aureus were under 3 months. Transmission between animals and humans requires further research. ST188 (14/58, 24.1%) was the common genotype of MSSA in S. aureus pneumonia in Chinese children, which was in agreement with the results reported by Qiao et al. (2014).
The prevalence of enterotoxins among S. aureus (57.9%, 62/107) isolated from pediatric patients, is actually consistent with that from adult (53.8–65.9%) in the same region (Chen et al., 2013; Gu et al., 2015a,b). ETs positive strains in MRSA and MSSA were 35 (71.4%, 35/49) and 27 (46.6%, 27/58) respectively. The prevalence of ETs in MRSA was lower than the occurrence of MRSA from surgical site infections (80.1%, 29/36) and SSTI (92.9%, 13/14) patients and higher than bloodstream infection (59.7%, 37/62) patients as our previously studies in Shanghai (Chen et al., 2013; Gu et al., 2015a,b). MRSA tended to carry the seb and sea genes, while MSSA tended to carry seg and sei genes, which was similar with the findings of our study on S. aureus infecting surgical site in orthopedic patients (Gu et al., 2015a). Further studies are warranted to get better understanding of this epidemic phenomenon in Shanghai.
Panton-Valentine leukocidin (PVL) is a bicomponent toxin, causing the lysis of leucocytes by forming a pore in their membrane, and it is a main virulence factor of S. aureus, independent of methicillin resistance (Gillet et al., 2011), and responsible for severe necrotising pneumonia. In 2006, Geng et al. found 22 MRSA (22/50, 40%) stains that were PVL- positive from children with community-onset pneumonia in China. In the same year, Han et al isolated 9 MRSA strains harboring lukS/F-PV from 8 infants with pneumonia and 1 adult with prostatitis in Shanghai (Han et al., 2010). In Qiao's study the pvl gene was detected in 27% of the isolates in children with invasive CA-SA infections from 2011 to 2013 in China (Qiao et al., 2014). In current study, a total of six lukS/F-PV -positive isolates were identified, and it was lower than the occurrences of lukS/F-PV-positive S. aureus previously reported (Geng et al., 2010; Han et al., 2010; Qiao et al., 2014). Three of lukS/F-PV -positive isolates in CA-MRSA were ST59 and the remaining three were ST6, ST217, and ST398 MSSA respectively.
When CA-MRSA infections is suspected the initial empiric antibiotic therapy including vancomycin or Clindamycin will be applied according to the American Academy of Pediatrics' Committee on Infectious Diseases' recommendations in 2009 (American Academy of Pediatrics Committee on Infectious Diseases: Staphylococcal Infections et al., 2009). Current study showed linezolid and vancomycin were more susceptible. The results of antimicrobial susceptibility test suggested that linezolid and vancomycin were appropriate antibiotics for treating S. aureus including CA-MRSA childhood pneumonia. CA-MRSA strains are resistance to β-lactams and cephalosporins and mostly susceptible to several non-β-lactam antibiotics (Shilo and Quach, 2011; Otter and French, 2012). Surprisingly MRSA in our study revealed low susceptibility to erythromycin (18.4%) and clindamycin (40.8%), some of which are inducible resistance. So Clindamycin may not be the most suitable empirical treatment of CA-MRSA childhood pneumonia in Shanghai. All Seven isolates susceptible to penicillin were β-lactamase producers, precluding penicillin in their treatment. Fluoroquinolones are unsuitable drug for children with pneumonia in the pediatric wards. This may be an explanation of the relatively low rate of resistance to ciprofloxacin in MRSA isolates. What is noteworthy is that all ST59-SCCmec IV-t172 were ciprofloxacin-intermediate. The microbiology laboratory study is warranted for development of an effective antimicrobial regimen in this area.
Conceived and designed the experiments: LH and PH. Performed the experiments: ZS and FG. Analyzed the data: YN. Contributed reagents/materials/analysis tools: LH, PH, and XG. Wrote the paper: ZS, FG, and LH.
This study was supported by National Natural Science Foundation of China (grant numbers 81472010 and 81471908). This study was also supported by the Shanghai 3-Year Plan of the Key Subjects Construction in Public Health-Infectious Diseases and Pathogenic Microorganism (grant number 15GWZK0102).
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Adegbola, R. A. (2012). Childhood pneumonia as a global health priority and the strategic interest of the Bill & Melinda Gates Foundation. Clin. Infect. Dis. 54(Suppl. 2), S89–S92. doi: 10.1093/cid/cir1051
Aires De Sousa, M., Bartzavali, C., Spiliopoulou, I., Sanches, I. S., Crisóstomo, M. I., and De Lencastre, H. (2003). Two international methicillin-resistant Staphylococcus aureus clones endemic in a university hospital in Patras, Greece. J. Clin. Microbiol. 41, 2027–2032. doi: 10.1128/JCM.41.5.2027-2032.2003
American Academy of Pediatrics Committee on Infectious Diseases: Staphylococcal Infections, Pickering, L. K., Baker, C. J., Kimberlin, Long, S. S., McMillan, J. A., et al. (eds.). (2009). Red Book: 2009 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics.
Carcillo, J. A., Castillo, L., Thomas, J., and Kissoon, N. (2009). Recognizing, understanding, and treating critical community acquired methicillin-resistant Staphylococcus aureus infection in children. Pediatr. Crit. Care Med. 10, 405–407. doi: 10.1097/PCC.0b013e3181a33038
Centers for Disease Control and Prevention (1999). Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. MMWR Morb. Mortal. Wkly. Rep. 48, 707–710.
Chen, X., Wang, W. K., Han, L. Z., Liu, Y., Zhang, H., Tang, J., et al. (2013). Epidemiological and genetic diversity of Staphylococcus aureus causing bloodstream infection in Shanghai, 2009-2011. PLoS ONE 8:e72811. doi: 10.1371/journal.pone.0072811
Chen, X., Yang, H. H., Huangfu, Y. C., Wang, W. K., Liu, Y., Ni, Y. X., et al. (2012). Molecular epidemiologic analysis of Staphylococcus aureus isolated from four burn centers. Burns 38, 738–742. doi: 10.1016/j.burns.2011.12.023
Chisti, M. J., Tebruegge, M., La Vincente, S., Graham, S. M., and Duke, T. (2009). Pneumonia in severely malnourished children in developing countries - mortality risk, aetiology and validity of WHO clinical signs: a systematic review. Trop. Med. Int. Health 14, 1173–1189. doi: 10.1111/j.1365-3156.2009.02364.x
Coombs, G. W., Nimmo, G. R., Bell, J. M., Huygens, F., O'brien, F. G., Malkowski, M. J., et al. (2004). Genetic diversity among community methicillin-resistant Staphylococcus aureus strains causing outpatient infections in Australia. J. Clin. Microbiol. 42, 4735–4743. doi: 10.1128/JCM.42.10.4735-4743.2004
David, M. Z., and Daum, R. S. (2010). Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin. Microbiol. Rev. 23, 616–687. doi: 10.1128/CMR.00081-09
Fossum, A. E., and Bukholm, G. (2006). Increased incidence of methicillin-resistant Staphylococcus aureus ST80, novel ST125 and SCCmecIV in the south-eastern part of Norway during a 12-year period. Clin. Microbiol. Infect. 12, 627–633. doi: 10.1111/j.1469-0691.2006.01467.x
Fuzi, M. (2016). Dissimilar fitness associated with resistance to fluoroquinolones influences clonal dynamics of various multiresistant bacteria. Front. Microbiol. 7:1017. doi: 10.3389/fmicb.2016.01017
Geng, W., Yang, Y., Wu, D., Zhang, W., Wang, C., Shang, Y., et al. (2010). Community-acquired, methicillin-resistant Staphylococcus aureus isolated from children with community-onset pneumonia in China. Pediatr. Pulmonol. 45, 387–394. doi: 10.1002/ppul.21202
Gillet, Y., Dumitrescu, O., Tristan, A., Dauwalder, O., Javouhey, E., Floret, D., et al. (2011). Pragmatic management of Panton-Valentine leukocidin-associated staphylococcal diseases. Int. J. Antimicrob. Agents 38, 457–464. doi: 10.1016/j.ijantimicag.2011.05.003
Gonzalez, B. E., Hulten, K. G., Dishop, M. K., Lamberth, L. B., Hammerman, W. A., Mason, E. O. Jr., et al. (2005). Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin. Infect. Dis. 41, 583–590. doi: 10.1086/432475
Gu, F. F., Han, L. Z., Chen, X., Wang, Y. C., Shen, H., Wang, J. Q., et al. (2015a). Molecular characterization of Staphylococcus aureus from surgical site infections in orthopedic patients in an orthopedic trauma clinical medical center in Shanghai. Surg. Infect. (Larchmt). 16, 97–104. doi: 10.1089/sur.2014.027
Gu, F. F., Hou, Q., Yang, H. H., Zhu, Y. Q., Guo, X. K., Ni, Y. X., et al. (2015b). Characterization of Staphylococcus aureus isolated from non-native patients with skin and soft tissue infections in Shanghai. PLoS ONE 10:e0123557. doi: 10.1371/journal.pone.0123557
Ho, P. L., Cheung, C., Mak, G. C., Tse, C. W., Ng, T. K., Cheung, C. H., et al. (2007). Molecular epidemiology and household transmission of community-associated methicillin-resistant Staphylococcus aureus in Hong Kong. Diagn. Microbiol. Infect. Dis. 57, 145–151. doi: 10.1016/j.diagmicrobio.2006.08.003
Ho, P. L., Chiu, S. S., Chan, M. Y., Gan, Y., Chow, K. H., Lai, E. L., et al. (2012). Molecular epidemiology and nasal carriage of Staphylococcus aureus and methicillin-resistant S. aureus among young children attending day care centers and kindergartens in Hong Kong. J. Infect. 64, 500–506. doi: 10.1016/j.jinf.2012.02.018
Holmes, A., Ganner, M., McGuane, S., Pitt, T. L., Cookson, B. D., and Kearns, A. M. (2005). Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease. J. Clin. Microbiol. 43, 2384–2390. doi: 10.1128/JCM.43.5.2384-2390.2005
Hsu, L. Y., Koh, Y. L., Chlebicka, N. L., Tan, T. Y., Krishnan, P., Lin, R. T., et al. (2006). Establishment of ST30 as the predominant clonal type among community-associated methicillin-resistant Staphylococcus aureus isolates in Singapore. J. Clin. Microbiol. 44, 1090–1093. doi: 10.1128/JCM.44.3.1090-1093.2006
Huang, Y. C., and Chen, C. J. (2011). Community-associated meticillin-resistant Staphylococcus aureus in children in Taiwan, 2000s. Int. J. Antimicrob. Agents 38, 2–8. doi: 10.1016/j.ijantimicag.2011.01.011
Ito, T., Kuwahara-Arai, K., Katayama, Y., Uehara, Y., Han, X., Kondo, Y., et al. (2014). Staphylococcal Cassette Chromosome mec (SCCmec) analysis of MRSA. Methods Mol. Biol. 1085, 131–148. doi: 10.1007/978-1-62703-664-1_8
Jarraud, S., Mougel, C., Thioulouse, J., Lina, G., Meugnier, H., Forey, F., et al. (2002). Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect. Immun. 70, 631–641. doi: 10.1128/IAI.70.2.631-641.2002
Köck, R., Brakensiek, L., Mellmann, A., Kipp, F., Henderikx, M., Harmsen, D., et al. (2009). Cross-border comparison of the admission prevalence and clonal structure of meticillin-resistant Staphylococcus aureus. J. Hosp. Infect. 71, 320–326. doi: 10.1016/j.jhin.2008.12.001
Li, M., Du, X., Villaruz, A. E., Diep, B. A., Wang, D., Song, Y., et al. (2012). MRSA epidemic linked to a quickly spreading colonization and virulence determinant. Nat. Med. 18, 816–819. doi: 10.1038/nm.2692
Mulvey, M. R., Macdougall, L., Cholin, B., Horsman, G., Fidyk, M., Woods, S., et al. (2005). Community-associated methicillin-resistant Staphylococcus aureus, Canada. Emerg. Infect. Dis. 11, 844–850. doi: 10.3201/eid1106.041146
Ning, X., Sun, M., Qiao, Y., Dong, F., Song, W., YaO, K., et al. (2015). Characterization of pediatric hospital-associated infection caused by methicillin-resistant Staphylococcus aureus in mainland China. Infect. Dis. (Lond). 47, 410–417. doi: 10.3109/00365548.2015.1006675
Otter, J. A., and French, G. L. (2012). Community-associated meticillin-resistant Staphylococcus aureus: the case for a genotypic definition. J. Hosp. Infect. 81, 143–148. doi: 10.1016/j.jhin.2012.04.009
Otter, J. A., Herdman, M. T., Williams, B., Tosas, O., Edgeworth, J. D., and French, G. L. (2013). Low prevalence of meticillin-resistant Staphylococcus aureus carriage at hospital admission: implications for risk-factor-based vs. universal screening. J. Hosp. Infect. 83, 114–121. doi: 10.1016/j.jhin.2012.10.008
Patel, J. B., Cockerill, F. R. III., Bradford, P. A., Eliopoulos, G. M., Hindler, J. A., Jenkins, S. G., et al. (2015). Performance Standards, for Antimicrobial Susceptibility Testing; Twenty-Fifth Informational Supplement. M100-S25 USA.
Qiao, Y., Ning, X., Chen, Q., Zhao, R., Song, W., Zheng, Y., et al. (2014). Clinical and molecular characteristics of invasive community-acquired Staphylococcus aureus infections in Chinese children. BMC Infect. Dis. 14:582. doi: 10.1186/s12879-014-0582-4
Shilo, N., and Quach, C. (2011). Pulmonary infections and community associated methicillin resistant Staphylococcus aureus: a dangerous mix? Paediatr. Respir. Rev. 12, 182–189. doi: 10.1016/j.prrv.2010.10.007
Tenover, F. C., McDougal, L. K., Goering, R. V., Killgore, G., Projan, S. J., Patel, J. B., et al. (2006). Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J. Clin. Microbiol. 44, 108–118. doi: 10.1128/JCM.44.1.108-118.2006
Wannet, W. J., Spalburg, E., Heck, M. E., Pluister, G. N., Tiemersma, E., Willems, R. J., et al. (2005). Emergence of virulent methicillin-resistant Staphylococcus aureus strains carrying Panton-Valentine leucocidin genes in The Netherlands. J. Clin. Microbiol. 43, 3341–3345. doi: 10.1128/JCM.43.7.3341-3345.2005
Xiao, M., Wang, H., Zhao, Y., Mao, L. L., Brown, M., Yu, Y. S., et al. (2013). National surveillance of methicillin-resistant Staphylococcus aureus in China highlights a still-evolving epidemiology with 15 novel emerging multilocus sequence types. J. Clin. Microbiol. 51, 3638–3644. doi: 10.1128/JCM.01375-13
Zhang, H., Xiao, M., Kong, F., O'sullivan, M. V., Mao, L. L., Zhao, H. R., et al. (2015). A multicentre study of meticillin-resistant Staphylococcus aureus in acute bacterial skin and skin-structure infections in China: susceptibility to ceftaroline and molecular epidemiology. Int. J. Antimicrob. Agents 45, 347–350. doi: 10.1016/j.ijantimicag.2014.12.014
Zhang, J., Gu, F. F., Zhao, S. Y., Xiao, S. Z., Wang, Y. C., Guo, X. K., et al. (2015). Prevalence and molecular epidemiology of Staphylococcus aureus among residents of seven nursing homes in Shanghai. PLoS ONE 10:e0137593. doi: 10.1371/journal.pone.0137593
Zhang, W., Shen, X., Zhang, H., Wang, C., Deng, Q., Liu, L., et al. (2009). Molecular epidemiological analysis of methicillin-resistant Staphylococcus aureus isolates from Chinese pediatric patients. Eur. J. Clin. Microbiol. Infect. Dis. 28, 861–864. doi: 10.1007/s10096-009-0706-8
Keywords: MRSA, Staphylococcus aureus, antimicrobial resistance, molecular characterization, childhood pneumonia
Citation: Song Z, Gu F-F, Guo X-K, Ni Y-X, He P and Han L-Z (2017) Antimicrobial Resistance and Molecular Characterization of Staphylococcus aureus Causing Childhood Pneumonia in Shanghai. Front. Microbiol. 8:455. doi: 10.3389/fmicb.2017.00455
Received: 09 August 2016; Accepted: 06 March 2017;
Published: 21 March 2017.
Edited by:Leonard Peruski, US Centers for Disease Control and Prevention, USA
Reviewed by:Fangyou Yu, First Affiliated Hospital of Wenzhou Medical University, China
Miklos Fuzi, Semmelweis University, Hungary
Copyright © 2017 Song, Gu, Guo, Ni, He and Han. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
†These authors have contributed equally to this work.